(NEXSTAR) – Patients using Ozempic and other GLP-1 drugs are reporting a complication not listed among the drug’s most common side effects. (We’re not talking about “Ozempic babies,” but that’s also a thing.) Dentists warn they’re seeing ...

"When I am lying in bed waiting for an acute flare-up of nausea to subside, I feel so depressed that I can’t help wondering if I can continue to live this way."

"This retrospective cohort study found that taking GLP-1RAs was associated with a reduced overall risk of cancer, including lower risks of endometrial, ovarian, and meningioma cancers, among patients with obesity or overweight," the team explained in their paper.

Ozempic and other GLP-1 drugs have become extremely popular for their ability to manage Type 2 diabetes symptoms and spur weight loss. A recent study found that about 4% of Americans took these meds last year.

A rumor that pharmaceutical companies behind popular weight-loss and diabetes medications like Ozempic faced lawsuits totaling more than $2 billion circulated online in August 2025.

In the past year or couple of years, you’ve likely heard a lot about Ozempic, most likely in the context of weight loss. Not for nothing — a lot of people turned to this diabetes medicine with the hopes that it would help them lose weight — and it did.

Medications like Ozempic mimic the GLP-1 hormone, so the user feels fuller for longer and doesn’t crave food as often.

Ozempic and other GLP-1 weight-loss medications are seeing explosive growth in popularity, but they’re also facing billions of dollars in lawsuits and growing concerns about long-term safety. Human Performance Coach and Transformation Specialist Coach Chris is in the house to break down what these medications really do,

Novo Nordisk announced Monday that US patients can now get a month’s supply of Ozempic, the blockbuster diabetes drug, for $499, for those who pay for medications on their own and don’t go through insurance.

No one stays on top forever. It’s a lesson that Ozempic maker Novo Nordisk may be painfully learning about. The Danish pharmaceutical company has enacted a hiring freeze—the latest sign of a sinking financial outlook for the once-titan of the obesity treatment world.

Imagine weight loss made easy… No, not with diet pills, GLP-1 jabs, not even with liposuction, or any risky surgeries. Wait, we’re not talking about some extremely strict diet, or exhausting yourself in the gym,